BRISTOL MYERS SQUIBB CO

Pharmaceutical Preparations·PRINCETON, NJ·FY end 12/31·CIK 14272

Board of Directors

11 members · 10 independent · FY 2025

Director	Role	Tenure	Age	Committees	Indep.	Annual fees
Christopher S. Boerner, Ph.D.	CEO and Director	3y	55	—	—	—
Theodore R. Samuels	Lead Independent Director	9y	71	NCGAudit		—
Peter J. Arduini	Director	10y	61	Comp		—
Deepak L. Bhatt, M.D., M.P.H., M.B.A.	Director	4y	58	TechComp		—
Julia A. Haller, M.D.	Director	7y	71	TechNCG		—
Manuel Hidalgo Medina, M.D., Ph.D.	Director	5y	58	NCGTech		—
Michael R. McMullen	Director	2y	65	AuditComp		—
Paula A. Price	Director	6y	64	AuditNCG		—
Derica W. Rice	Director	6y	61	AuditComp		—
Karen H. Vousden, Ph.D.	Director	8y	68	CompTech		—
Phyllis R. Yale	Director	7y	68	AuditTech		—

10-K Item 1A — YoY changes

Need at least two years of 10-K filings to compute. Will populate once both this year's and last year's 10-Ks have been ingested.

Clawback, anti-hedging, stock ownership, and related-party policies will populate from extracted proxy sections.